Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed herewith the Investor Presentation on Un-Audited Financial Results of the Company for the 3rd Quarter and nine months ended 31st December, 2022. Q3FY23 Quarterly Result Announced for Krishna Institute of Medical Sciences Ltd.
Krishna Institute of Medical Sciences announced Q3FY23 results: Consolidated Q3FY23: Revenue from operations grew by 42.8% YoY basis to Rs 5,622 million. Adjusted EBITDA (excluding other income, INDAS adjustments, and one-off items) grew by 14% on a YoY basis to Rs 1,470 million. Adjusted EBITDA margin stands at 26.2%; Ex Nagpur stands at 27.2% (an improvement of 0.1% QoQ). Recent acquisitions i.e. Sunshine & Nagpur hospital, have shown sequential improvement (ex one-off items) in the EBITDA margin. For Q3FY23, Sunshine EBITDA stands at 21.9%, Nagpur EBITDA stands at 11.1%. During the quarter, the company acquired an additional stake in three of its subsidiaries: 1.92% in Sunshine hospital, 4.07% in Kondapur hospital and 7.79% in Srikakulam Hospitals. Going forward, we aim to acquire a further stake in these units. Company has disposed one of its step-down subsidiaries “Suryateja Healthcare Private Limited” (Sunshine hospital Karimnagar) w.e.f. December 1, 2022. Commenting on the performance, Dr. B. Bhaskara Rao, Chairman & Managing Director, said: “The focus for us in Q3FY23 has been on the continued integration of sunshine and Nagpur units. We are confident that the results of these will see fruition in the following 8 to 10 quarters. Onboarding of doctors across units was at a brisk pace. The influx of patients across units has been steady. Despite a small dip in IP numbers, we have recorded growth in our ARPOB and ARPP. Number changes due to seasonality are given in this sector, and we are focused on the bigger picture of providing quality affordable care, which will eventually help us shore up volumes and achieve the targets set. We remain optimistic that Q4FY23 will see steady growth and help us achieve the targets set for FY23." Result PDF Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the above stated subject, please find enclosed herewith the Press Release on the Un-Audited Financial Results of the Company for the 3rd Quarter and nine months ended 31st December, 2022. Krishna Institute of Medical Sciences Ltd - 543308 - Approval Of Un-Audited Financial Results For The 3Rd Quarter And Nine Months Ended 31St December, 2022
Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors have approved the Un-Audited Standalone and Consolidated Financial Results of the Company along with the Limited Review Report for the 3rd Quarter and nine months ended 31st December, 2022 which are enclosed to this letter. Krishna Institute of Medical Sciences Ltd - 543308 - Board Meeting Outcome for Outcome Of Board Meeting Held On 09Th February 2023 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Further to our intimations dated 28th January 2023, the Board of Directors, at its meeting held today, has approved the Un-Audited Standalone and Consolidated Financial Results of the Company for the 3rd Quarter and nine months ended 31st December 2022 together with Limited Review Reports which have been reviewed by the Audit Committee and approved by the Board of Directors. Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We would like to inform you that Dr. Bhaskara Rao Bollineni - Chairman & Managing Director, Dr. Abhinay Bollineni - Executive Director & CEO, and Mr. Vikas Maheshwari - Chief Financial Officer, would participate in a conference call with analysts and investors, being hosted by IIFL Securities on Friday 10th February 2023, at 12:00 Noon IST, to discuss the company's business strategy and outlook post the declaration of Q3FY23 financial results. Krishna Institute of Medical Sciences Ltd - 543308 - Board Meeting Intimation for The Approval Of The Un-Audited (Standalone & Consolidated) Financial Results Of The Company For The 3Rd Quarter And Nine Months Ended December 31, 2022.
Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 ,inter alia, to consider and approve the Un-Audited (Standalone & Consolidated) Financial results of the company for the 3rd quarter and nine months ended December 31, 2022 Krishna Institute of Medical Sciences Ltd - 543308 - Publication Of The Postal Ballot Notice In Newspaper.
The Publication of the Postal Ballot Notice in News paper for approval of the following resolutions: 1. Appointment of Mr. Shantanu Rastogi as Non-Executive Director of the Company, liable to retire by rotation. 2. To consider and approve for alteration of Article 74 of the Articles of Association of the Company. 3. To consider and approve the issue of Non-Convertible Debentures Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Diversification / Disinvestment
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI (LODR) Regulations, 2015), we wish to inform you that M/s. Suryateja Healthcare Private Limited, a step-down subsidiary of the Company, in which the Company, indirectly through its subsidiary i.e Sarvejana Healthcare Private Limited holds 100% holding has disinvested its entire stake in favour of group of doctors [Dr. Karampudi Kamalakar, Dr. Nalamaru Vamsi, Dr. Suresh Kumar Thatipamula, Ms. Divya Puskur, and Dr. Omprakash Tumma (collectively to be called as 'Purchaser')] under an agreement to takeover company by transfer of shares. Consequent upon the said dis-investment, Suryateja Healthcare Private Limited, ceased to be a step-down subsidiary of the Company. Krishna Institute of Medical Sciences Ltd - 543308 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
The postal ballot notice seeking consent of the members through voting by electronic means to transact the business as set out in the Postal Ballot Notice dated 4th January, 2023 in respect of the following Ordinary and Special Resolutions: 1. Appointment of Mr. Shantanu Rastogi as Non-Executive Director of the Company, liable to retire by rotation. 2. To consider and approve for alteration of Article 74 of the Articles of Association of the Company. 3. To consider and approve the issue of Non-Convertible Debentures.